181 related articles for article (PubMed ID: 33991998)
1. Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury.
Li L; Tao S; Guo F; Liu J; Huang R; Tan Z; Zeng X; Ma L; Fu P
Int Immunopharmacol; 2021 Jul; 96():107760. PubMed ID: 33991998
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury.
Tan Z; Guo F; Huang Z; Xia Z; Liu J; Tao S; Li L; Feng Y; Du X; Ma L; Fu P
J Cell Mol Med; 2019 Sep; 23(9):6260-6270. PubMed ID: 31286669
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P
Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Fatty Acid-Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition.
Feng Y; Guo F; Xia Z; Liu J; Mai H; Liang Y; Zhu G; Li Y; Bai L; Li L; Huang R; Shi M; Ma L; Fu P
Front Immunol; 2020; 11():566535. PubMed ID: 33101287
[TBL] [Abstract][Full Text] [Related]
5. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.
Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H
Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis.
Wang B; Xu J; Ren Q; Cheng L; Guo F; Liang Y; Yang L; Tan Z; Fu P; Ma L
Cell Death Dis; 2022 Apr; 13(4):333. PubMed ID: 35410456
[TBL] [Abstract][Full Text] [Related]
7. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M; Kemmerer M; Brüne B; Namgaladze D
Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
[TBL] [Abstract][Full Text] [Related]
8. Genetic inhibition of FABP4 attenuated endoplasmic reticulum stress and mitochondrial dysfunction in rhabdomyolysis-induced acute kidney injury.
Liu J; Huang R; Li X; Guo F; Li L; Zeng X; Ma L; Fu P
Life Sci; 2021 Mar; 268():119023. PubMed ID: 33434534
[TBL] [Abstract][Full Text] [Related]
9. Remimazolam attenuates inflammation and kidney fibrosis following folic acid injury.
Song J; Yu W; Chen S; Huang J; Zhou C; Liang H
Eur J Pharmacol; 2024 Mar; 966():176342. PubMed ID: 38290569
[TBL] [Abstract][Full Text] [Related]
10. FABP4 contributes to renal interstitial fibrosis via mediating inflammation and lipid metabolism.
Qiao Y; Liu L; Yin L; Xu L; Tang Z; Qi Y; Mao Z; Zhao Y; Ma X; Peng J
Cell Death Dis; 2019 May; 10(6):382. PubMed ID: 31097687
[TBL] [Abstract][Full Text] [Related]
11. FABP4 inhibitor attenuates inflammation and endoplasmic reticulum stress of islet in leptin receptor knockout rats.
Yao F; Jiang DD; Guo WH; Guo LS; Gao MM; Bai Y; Wang X; Zhang LS
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12808-12820. PubMed ID: 33378030
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway.
Wang X; Xue N; Zhao S; Shi Y; Ding X; Fang Y
Cell Death Dis; 2020 Aug; 11(8):620. PubMed ID: 32796834
[TBL] [Abstract][Full Text] [Related]
13. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
[TBL] [Abstract][Full Text] [Related]
14. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury.
Huang R; Shi M; Guo F; Feng Y; Feng Y; Liu J; Li L; Liang Y; Xiang J; Lei S; Ma L; Fu P
Front Pharmacol; 2018; 9():917. PubMed ID: 30135658
[TBL] [Abstract][Full Text] [Related]
16. Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy.
Taguchi S; Azushima K; Yamaji T; Urate S; Suzuki T; Abe E; Tanaka S; Tsukamoto S; Kamimura D; Kinguchi S; Yamashita A; Wakui H; Tamura K
Sci Rep; 2021 Dec; 11(1):23587. PubMed ID: 34880315
[TBL] [Abstract][Full Text] [Related]
17. Fatty Acid Binding Protein-4 Silencing Inhibits Ferroptosis to Alleviate Lipopolysaccharide-induced Injury of Renal Tubular Epithelial Cells by Blocking Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling.
Xu S; Luo J; Wang Y; Chen X
; 2024 Jan; 67(1):47-56. PubMed ID: 38780272
[TBL] [Abstract][Full Text] [Related]
18. Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis.
Stallons LJ; Whitaker RM; Schnellmann RG
Toxicol Lett; 2014 Jan; 224(3):326-32. PubMed ID: 24275386
[TBL] [Abstract][Full Text] [Related]
19. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
[TBL] [Abstract][Full Text] [Related]
20. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
